The New Normal Five years ago, COVID-19 was declared a global pandemic, marking the official onset of a healthcare crisis ...
Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...
13d
In essence, the future of AI is inextricably linked to advancements in data management, making it an indispensable enabler of ...
AI-driven drug discovery can analyse millions of chemical compounds in ... Of these drugs, three are undergoing Phase II ...
Interesting Engineering on MSN10d
Video: US unveils ‘scientist’ humanoid robot to boost drug discovery, experimentsA US clinical-stage biotechnology company has introduced the first bipedal humanoid robot in its AI-driven, fully automated ...
Insilico Medicine, whose Hong Kong IPO application lapsed in 2024, is still considering going public in the city, said ...
Eradivir, a clinical-stage small molecule immunotherapy biotech company, announced it has begun a Phase 2 challenge study with its antiviral therapeutic, EV25. The study will provide safety and ...
Two Eradivir employees conduct research on the company's EV25 influenza therapeutic. Eradivir, a clinical stage biotech ...
For more information on the Phase 1b clinical trial, visit: https://clinicaltrials.gov/study/NCT06732180 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback